CTRI Number |
CTRI/2023/11/059441 [Registered on: 02/11/2023] Trial Registered Prospectively |
Last Modified On: |
24/08/2023 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Ayurveda |
Study Design |
Randomized, Parallel Group Trial |
Public Title of Study
|
Effect of Gomutra haritaki on Diabetes mellitus type 2 |
Scientific Title of Study
|
A clinical study to evaluate the efficacy of Gomutra haritaki yog in the management of prameha(Madhumeha)W.S.R. Diabete mellitus type 2 |
Trial Acronym |
NIL |
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Seeta Rajoria |
Designation |
Associate professor & PhD Scholar |
Affiliation |
Madan Mohan Malviya Govt. Ayurved College Udaipur |
Address |
P.G. Dept. of Kayachikitsa Madan Mohan Malviya Govt. Ayurved
College Udaipur
Udaipur
Udaipur RAJASTHAN 313001 India |
Phone |
9414605849 |
Fax |
|
Email |
sitarajoria29@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Brahmanand Sharma |
Designation |
Associate Professor & guide |
Affiliation |
Dr.Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur |
Address |
P.G. Dept. of Kayachikitsa Dr.Sarvepalli Radhakrishnan Rajasthan Ayurved
University,Jodhpur P.G. Dept. of Kayachikitsa Dr.Sarvepalli Radhakrishnan Rajasthan Ayurved
University,Jodhpur Jodhpur RAJASTHAN 324002 India |
Phone |
7976964483 |
Fax |
|
Email |
bkmudgal9@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Dr Brahmanand sharma |
Designation |
Associate professor & guide |
Affiliation |
Dr.Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur |
Address |
P.G. Dept. of Kayachikitsa Dr.Sarvepalli Radhakrishnan Rajasthan Ayurved
University, Jodhpur P.G. Dept. of Kayachikitsa Dr.Sarvepalli Radhakrishnan Rajasthan Ayurved
University, Jodhpur Jodhpur RAJASTHAN 324002 India |
Phone |
7976964483 |
Fax |
|
Email |
bkmudgal9@gmail.com |
|
Source of Monetary or Material Support
|
Madan Mohan Malviya Govt Ayurved College Udaipur |
|
Primary Sponsor
|
Name |
Madan Mohan Malviya Govt Ayurved College Udaipur |
Address |
Madan Mohan Malviya Govt. Ayurved College, Radaji Circle
Ambamata, Udaipur 313001
|
Type of Sponsor |
Government medical college |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
DrBrhmanand Sharma |
Madan Mohan Malviya Govt. Ayurved College Udaipur |
P.G. Dept. of
Kayachikitsa Madan
Mohan Malviya Govt.
Ayurved College
Udaipur Udaipur
RAJASTHAN
Udaipur
RAJASTHAN
Udaipur RAJASTHAN |
7976964483
bkmudgal9@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Dr. Sarvepalli Radhakrishnan Rujasthan Ayurved Uniersity, Jodhpur Post Graduate Institute of Ayurved Institutional Ethics Committee |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition:E119||Type 2 diabetes mellitus without complications. Ayurveda Condition: PRAMEHAH, |
|
Intervention / Comparator Agent
|
sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | 1 | Intervention Arm | Drug | Classical | | (1) Medicine Name: GomutraSadhitaHaritakiYoga, Reference: chakradat , Route: Oral, Dosage Form: Churna/ Powder, Dose: 5(g), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 90 Days, anupAna/sahapAna: No, Additional Information: - | 2 | Comparator Arm | Lifestyle | - | - | Dinacarya: , Ritucarya: , Acara Rasayana:, Other:, Pathya/Apathya:yes, Pathya:yava,sarshapa tail,tikta kashaya pradhana dravyas for 90 days , Apathya:madhura,amla,lavana rasa pradhana dravyas
for 90 days |
|
|
Inclusion Criteria
|
Age From |
25.00 Year(s) |
Age To |
70.00 Year(s) |
Gender |
Both |
Details |
1. The patients having clinical sign & symptoms of the Prameha (Madhumeh) & willing for
trial.
2. The patients who ages in between 25 – 70 years will be selected
3.international diagnosis criteria for diabetes (WHO)
(A) Patient having F.B.S. level >125 mg/dl <250 mg/dl (6.9 mmol/lit.)
(B) P.P.B.S. level >180 mg/dl to <350 mg/dl (10 mmol/lit.) will be selected for the trial
4. Either sex of different socio-economic groups. |
|
ExclusionCriteria |
Details |
1. IDDM patients
2. Gestational diabetes.
3. Diabetes Mellitus produced due to other illnesses like Acromegaly, Cushing’s syndrome,
pancreatic disorders etc.
4. Acute complications Diabetic Keto-acidosis & hyperglycemic hyperosmolar coma.
5. Pregnant & Lactating Mother.
6. History of severe unstable angina, MI, CVA, Renal failure |
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
An Open list of random numbers |
Blinding/Masking
|
Not Applicable |
Primary Outcome
|
Outcome |
TimePoints |
Symptoms like
Polyurea, Turbidity, burning sensation in palm and sole, polydipsia, fatigue, general weakness, polyphagia, sugar in the urine, and cramps will be analyzed
|
3 months |
|
Secondary Outcome
|
Outcome |
TimePoints |
fasting blood sugar & post prandial blood sugar will be analyzed |
1 month & 2 months |
|
Target Sample Size
|
Total Sample Size="100" Sample Size from India="100"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 3 |
Date of First Enrollment (India)
|
10/11/2023 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="0" Months="3" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
N/A |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
This is a parallel group study to evaluate the efficacy of gomutra haritaki in the management of diabetes mellitus type 2.In this study,group A,50 patients will be administered with gomutra haritaki, 5 gm, od for the duration of 3 months.And group B,50 patients will be advised to follow pathya-apathya of prameha for 3 months |